Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0107548002
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02249332 | APOTEX INC | APO-METHYLPHENIDATE | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Marketed | 02266687 | APOTEX INC | APO-METHYLPHENIDATE SR | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Cancelled Pre Market | 02484919 | BARD PHARMACEUTICALS (1990) INC | BAR-METHYLPHENIDATE HCL CR | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Marketed | 02277158 | ELVIUM LIFE SCIENCES | BIPHENTIN | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Approved | 02553074 | IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC. | JORNAY PM | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Cancelled Post Market | 02326256 | PRO DOC LIMITEE | METHYLPHENIDATE | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Cancelled Post Market | 00422983 | TECHNILAB PHARMA INC. | METHYLPHENIDATE TAB 20MG | Human | No | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Cancelled Pre Market | 02274302 | NOVOPHARM LIMITED | NOVO-METHYLPHENIDATE | Human | No | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20.00 MG |
Cancelled Post Market | 02126486 | PHARMEL INC | PHL-METHYLPHENIDATE | Human | No | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Marketed | 00585009 | PHARMASCIENCE INC | PMS-METHYLPHENIDATE | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Marketed | 02536978 | PHARMASCIENCE INC | PMS-METHYLPHENIDATE CR | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Marketed | 02541602 | KYE PHARMACEUTICALS INC. | QUILLIVANT ER CHEWABLE TABLETS | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Cancelled Post Market | 02230322 | TEVA CANADA LIMITED | RATIO-METHYLPHENIDATE | Human | No | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Cancelled Post Market | 00005614 | NOVARTIS PHARMACEUTICALS CANADA INC | RITALIN 20MG | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Cancelled Post Market | 00632775 | NOVARTIS PHARMACEUTICALS CANADA INC | RITALIN-SR TAB 20MG | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Cancelled Pre Market | 02455854 | SANDOZ CANADA INCORPORATED | SANDOZ METHYLPHENIDATE | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Cancelled Post Market | 02320312 | SANDOZ CANADA INCORPORATED | SANDOZ METHYLPHENIDATE SR | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Application information
Related information
Contact us
Version 4.0.3